论文部分内容阅读
目的:探索沙美特罗替卡松粉吸入剂对慢性阻塞性肺病的临床治疗效果。方法:选取2014年1月至2015年1月我院收治的慢性阻塞性肺病患者60例作为研究对象,随机分成试验组和对照组,平均每组30名患者。对照组的患者应用常规治疗,试验组在对照组治疗基础上给予沙美特罗替卡松粉吸入剂治疗。观察患两组者治疗后的临床效果及肺功能改善情况。结果:治疗后试验组总有效率为90.00%,对照组总有效率为60.00%,差异具有统计学意义(P<0.05);治疗后实验组肺功能改善情况明显优于对照组,结果具有统计学意义(P<0.05)。结论:沙美特罗替卡松粉吸入剂对慢性阻塞性肺病的临床治疗效果显著,可更好的改善患者肺功能指标,值得在临床上推广。
Objective: To explore the clinical effect of salmeterol and fluticasone powder inhaler on chronic obstructive pulmonary disease. Methods: Sixty patients with chronic obstructive pulmonary disease admitted to our hospital from January 2014 to January 2015 were selected as study subjects and randomly divided into experimental group and control group with an average of 30 patients in each group. The control group of patients with conventional treatment, the experimental group in the control group based on the treatment with salmeterol and fluticasone powder inhalation therapy. Observe the clinical effects and the improvement of pulmonary function in both groups after treatment. Results: After treatment, the total effective rate was 90.00% in the experimental group and 60.00% in the control group, the difference was statistically significant (P <0.05); after treatment, the improvement of pulmonary function in the experimental group was obviously better than that in the control group Significance (P <0.05). Conclusion: Salmeterol truss powder inhalation on chronic obstructive pulmonary disease clinical treatment of significant effect, can better improve patients with pulmonary function indicators, it is worth in the clinical promotion.